Alyeska Investment Group’s Verastem VSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.75M Buy
2,289,625
+239,625
+12% +$1.16M 0.02% 444
2026
Q1
$10.9M Buy
+2,050,000
New +$12.6M 0.03% 389
2025
Q3
Sell
-131,770
Closed -$547K 728
2025
Q2
$547K Buy
+131,770
New +$825K ﹤0.01% 520
2024
Q4
Sell
-1,859,954
Closed -$5.56M 671
2024
Q3
$5.56M Buy
1,859,954
+1,159,954
+166% +$3.15M 0.03% 342
2024
Q2
$2.09M Buy
+700,000
New +$5.77M 0.01% 410
2023
Q3
Sell
-156,762
Closed -$1.17M 639
2023
Q2
$1.17M Buy
+156,762
New +$1.09M 0.01% 445

Other funds holding VSTM

Alyeska Investment Group's VSTM Position: Q2 2026 in Review

Alyeska Investment Group increased its Verastem (VSTM) stake by 12% in Q2 2026, buying an estimated $1.16M and bringing the position to 2,289,625 shares worth $8.75M. The position accounts for 0.02% of the portfolio, ranked #444.

Alyeska Investment Group first reported a position in VSTM in Q2 2023 and has held it in 6 quarters since. The position peaked at $10.9M in Q1 2026. 157 funds tracked by Wall St. Rank hold VSTM as of Q2 2026.

  • Alyeska Investment Group held 2,289,625 shares of Verastem worth $8.75M as of Q2 2026.
  • Alyeska Investment Group bought 239,625 Verastem shares in Q2 2026, an estimated $1.16M.
  • Verastem made up 0.02% of Alyeska Investment Group's portfolio in Q2 2026, its #444 holding.
  • Alyeska Investment Group first reported a position in Verastem in Q2 2023 and has held it in 6 quarters since.
  • Alyeska Investment Group's Verastem position peaked at $10.9M in Q1 2026.
  • 157 funds tracked by Wall St. Rank held Verastem as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.